Global Molecular Diagnostics Infectious Disease Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Molecular Diagnostics Infectious Disease Testing market size was valued at US$ 6024 million in 2024 and is forecast to a readjusted size of USD 9582 million by 2031 with a CAGR of 6.9% during review period.
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
Molecular diagnostics is a technology that diagnoses diseases by detecting and analyzing biomarkers (such as DNA, RNA, proteins, etc.). In infectious disease testing, molecular diagnostics can be used to detect the nucleic acid sequences of pathogens to determine whether infection is viral or bacterial. Traditional infectious disease detection methods usually require tedious culture and detection steps, while molecular diagnostics can extract nucleic acids directly from samples and perform rapid and accurate detection. This method has the advantages of high sensitivity, high specificity and rapid response, which can detect the disease at an early stage, avoid the spread of the disease, and better control the outbreak of infectious diseases. At present, molecular diagnosis has been widely used in the detection of various infectious diseases, such as AIDS, hepatitis, tuberculosis, influenza, new coronavirus, etc., providing important support and help for the prevention and control of infectious diseases.
This report is a detailed and comprehensive analysis for global Molecular Diagnostics Infectious Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Diagnostics Infectious Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Molecular Diagnostics Infectious Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Molecular Diagnostics Infectious Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Molecular Diagnostics Infectious Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Diagnostics Infectious Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Diagnostics Infectious Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, BD, bioMérieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex, GenMark Diagnostics, Qiagen NV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Diagnostics Infectious Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Market segment by Application
Hospital
Laboratory Research
Market segment by players, this report covers
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Diagnostics Infectious Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Diagnostics Infectious Disease Testing, with revenue, gross margin, and global market share of Molecular Diagnostics Infectious Disease Testing from 2020 to 2025.
Chapter 3, the Molecular Diagnostics Infectious Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Molecular Diagnostics Infectious Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Infectious Disease Testing.
Chapter 13, to describe Molecular Diagnostics Infectious Disease Testing research findings and conclusion.
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
Molecular diagnostics is a technology that diagnoses diseases by detecting and analyzing biomarkers (such as DNA, RNA, proteins, etc.). In infectious disease testing, molecular diagnostics can be used to detect the nucleic acid sequences of pathogens to determine whether infection is viral or bacterial. Traditional infectious disease detection methods usually require tedious culture and detection steps, while molecular diagnostics can extract nucleic acids directly from samples and perform rapid and accurate detection. This method has the advantages of high sensitivity, high specificity and rapid response, which can detect the disease at an early stage, avoid the spread of the disease, and better control the outbreak of infectious diseases. At present, molecular diagnosis has been widely used in the detection of various infectious diseases, such as AIDS, hepatitis, tuberculosis, influenza, new coronavirus, etc., providing important support and help for the prevention and control of infectious diseases.
This report is a detailed and comprehensive analysis for global Molecular Diagnostics Infectious Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Diagnostics Infectious Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Molecular Diagnostics Infectious Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Molecular Diagnostics Infectious Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Molecular Diagnostics Infectious Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Diagnostics Infectious Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Diagnostics Infectious Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, BD, bioMérieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex, GenMark Diagnostics, Qiagen NV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Diagnostics Infectious Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Market segment by Application
Hospital
Laboratory Research
Market segment by players, this report covers
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Diagnostics Infectious Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Diagnostics Infectious Disease Testing, with revenue, gross margin, and global market share of Molecular Diagnostics Infectious Disease Testing from 2020 to 2025.
Chapter 3, the Molecular Diagnostics Infectious Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Molecular Diagnostics Infectious Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Infectious Disease Testing.
Chapter 13, to describe Molecular Diagnostics Infectious Disease Testing research findings and conclusion.
Table of Contents
119 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
